ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.